Another Treatment Breakthrough at DHR Health 

First Endoscopic Gallbladder Drainage Procedure in the RGV

Translate to Spanish or other 102 languages!

DHR Health Advanced Endoscopy Institute is proud to announce the introduction of Endoscopic Gallbladder Drainage to the Rio Grande Valley. The first procedure of its kind was successfully performed on a female patient of advanced age at DHR Health. Image courtesy of DHR Health
DHR Health Advanced Endoscopy Institute is proud to announce the introduction of Endoscopic Gallbladder Drainage to the Rio Grande Valley. The first procedure of its kind was successfully performed on a female patient of advanced age at DHR Health. Image courtesy of DHR Health
- Advertisement -

DHR Health Advanced Endoscopy Institute is proud to announce the introduction of Endoscopic Gallbladder Drainage to the Rio Grande Valley. The first procedure of its kind was successfully performed on a female patient of advanced age at DHR Health. 

Utilizing endoscopic ultrasound guidance, Dr. Juan Sanchez identified and accessed the gallbladder through the stomach, successfully placing a metal stent to alleviate inflammation and pain. 

Dr. Sanchez said this minimally invasive technique provides a critical alternative for treating Acute Cholecystitis when the gallbladder becomes inflamed or swollen, particularly for patients who are non-operative candidates. 

- Advertisement -

The patient is doing great following post-operative appointments with Dr. Sanchez. This procedure marks a significant advancement in DHR Health’s commitment to offering cutting-edge, patient-centered care. 

A native of the RGV, Dr. Sanchez serves as a gastroenterologist and an advanced endoscopy specialist at DHR Health. For an endoscopy consult or to schedule an appointment call (956) 362-8840.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.
- Advertisement -